Palvella Therapeutics to host earnings call

Palvella Therapeutics, Inc. will hold a conference call on March 31, 2026, to discuss its full-year 2025 financial results and provide a corporate update. The company, which is in the clinical-stage of development, will offer insights into its financial performance and strategic progress. Investors and interested parties can expect details regarding the company's pipeline, clinical trial advancements, and future business outlook during the call. This event is crucial for understanding Palvella's current standing and trajectory.